The BTA is delighted to announce that Cerus Corporation has joined the association’s membership.

Cerus is a company with a three-decade history in the field of transfusion medicine, with a consistent and unwavering focus on securing blood safety and availability around the globe.

Cerus is dedicated solely to safeguarding the world’s blood supply.  The company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood.  The company’s technology is a system for pathogen inactivation of platelets and plasma that is available globally.

Visit Cerus.com to learn more.

Cookie settings

We use cookies on blood-transfusion-association.com (e.g. tracking and analytical cookies), with which an analysis and measurement of user data is possible. Further information can be found in the